UNSPSC 85562009: Revision of autologous tissue substitute in right ear, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right ear, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 09WH37Z

UNSPSC 85562009 Revision of autologous tissue substitute in right ear, percutaneous approach is a Commodity code that does not align with state and local procurement activity reflected in the recent opportunities. The six recent solicitations tagged under this code—spanning independent medical evaluation services for retirement disability determinations, surgical benefit carve-out programs, occupational medical surveillance, specialty and emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—represent administrative healthcare procurement and personnel services rather than tissue revision procedures or medical device procurement. The code's nominal scope suggests surgical supplies or tissue-engineering products for otologic procedures, but the opportunities show state and local bodies instead procuring healthcare administration contracts, medical staff augmentation, and employee benefit plan services. No recent opportunities involve autologous tissue substitutes, revision procedures, or percutaneous otologic interventions.

The issuing bodies include county departments of probation and human resources (Harris County, Collier County, Santa Clara County), municipal pension boards and retirement offices (City of Phoenix), municipal human resources functions (City of Long Beach), and a state transportation agency (Washington State Department of Transportation). The geographic spread covers Arizona, California, Florida, and Washington. Because the recent opportunities show no procurement activity that matches the code's stated scope—revision of autologous tissue substitutes in the ear—this code does not currently represent a decision-relevant procurement vector for vendors in medical device, tissue engineering, or surgical supply categories.